指南与共识胸部CT

基于CT影像组学的一致性聚类对临床T1期肺腺癌患者风险分层具有潜力

Consensus clustering based on CT radiomics has potential for risk stratification of patients with clinical T1 stage lung adenocarcinoma.
指南 / 共识 · BMC Med Imaging · 2025-07-01

本研究回顾性分析2018年9月至2021年5月手术切除且病理确诊的肺腺癌患者的临床、病理及CT影像资料,基于CT影像组学特征进行无监督一致性聚类,497例患者被分为2个聚类(聚类1为258例,51.9%;聚类2为239例,48.1%)。聚类1与聚类2在微乳头成分、实体成分、STAS及Ki-67增殖指数上差异有统计学意义(p < 0.001),在淋巴结转移和VPI上也差异有统计学意义(p = 0.031和0.012)。结论认为基于CT影像组学的一致性聚类可识别影像组学特征与病理风险因素及基因组特征的关联,有助于临床T1期肺腺癌患者的临床风险分层。

要点

  • 基于CT影像组学的一致性聚类可将临床T1期肺腺癌分为2个聚类。
  • 聚类1与聚类2在微乳头成分、实体成分、STAS及Ki-67增殖指数上差异有统计学意义(p < 0.001)。
  • 聚类1与聚类2在淋巴结转移和VPI上差异有统计学意义(p = 0.031和0.012)。

核心结论

  • 基于CT影像组学的一致性聚类可识别临床T1期肺腺癌影像组学特征与病理风险因素及基因组特征的关联,有助于该人群的临床风险分层。

研究设计与样本

  • 回顾性分析2018年9月至2021年5月手术切除且病理确诊的肺腺癌患者的临床、病理及CT影像资料,共497例,基于CT影像组学特征进行无监督一致性聚类分析。

诊断标准与关键数值

  • 497例患者被确定分为2个聚类(最优),聚类1为258例(51.9%),聚类2为239例(48.1%);聚类1与聚类2在微乳头成分、实体成分、STAS及Ki-67增殖指数上差异有统计学意义(p < 0.001),在淋巴结转移和VPI上差异有统计学意义(p = 0.031和0.012);在浸润性腺癌和亚实性病灶的亚组分析中,微乳头成分、实体成分、STAS及Ki-67增殖指数差异有统计学意义(p < 0.05);聚类1与聚类2仅在HER2突变上差异有统计学意义(p < 0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: This study aimed to clinically risk-classify patients with clinical stage T1 LUAD based on consensus clustering of CT radiomics to help clinics provide personalized treatment strategies for patients with early stage LUAD.

MATERIALS: Clinical, pathological and CT imaging data of patients who underwent surgical resection and pathologically confirmed lung adenocarcinoma from September 2018 to May 2021 were retrospectively analysed. The clinical and pathological information included age, gender, smoking history, tumor location, pathological subtype, infiltration level, lymph node metastasis (LNM), visceral pleural infiltration (VPI), lymphovascular invasion (LVI), spread through air space (STAS), Ki-67 proliferation index, and gene mutation information. Unsupervised consensus clustering analysis was performed based on the radiomic features of CT images to determine the optimal cluster values and evaluate the effect of consensus clustering. Patients were grouped according to the consensus clustering results, and compared with the histopathological characteristics of the tumors, genomic information and subgroup analyses were performed in invasive adenocarcinomas and sub-solid lesions.

RESULTS: Totally 497 cases were determined to be classified into 2 clusters (optimal), with 258 (51.9%) cases in cluster 1 and 239 (48.1%) cases in cluster 2. There were statistically significant differences between cluster 1 and cluster 2 in micropapillary component, solid component, STAS, and Ki-67 proliferation index (p < 0.001), as well as statistically significant differences in LNM and VPI (p = 0.031 and 0.012 respectively). Additionally, micropapillary component, solid component, STAS, and Ki-67 proliferation index were also statistically different in subgroup analyses of invasive adenocarcinomas and sub-solid foci (p < 0.05). The clusters 1 and 2 were statistically different only in HER2 mutations (p < 0.001).

CONCLUSION: Consensus clustering based on CT radiomics can identify the associations of radiomic features between pathological risk factors and genomic features in clinical stage T1 lung adenocarcinoma, which can help clinical risk stratification of stage T1 lung adenocarcinoma patients.

CLINICAL TRIAL NUMBER: Not applicable.

来源:BMC Med Imaging,查看原文。版权归原作者所有。

引用

  1. Dong H, Li Y, Zhao L, et al. Consensus clustering based on CT radiomics has potential for risk stratification of patients with clinical T1 stage lung adenocarcinoma. BMC Med Imaging. 2025. PMID: 40596894. doi:10.1186/s12880-025-01795-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。